絞り込み

16603

広告

Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.

著者 Shinozaki S , Osawa H , Kobayashi Y , Sakamoto H , Hayashi Y , Miura Y , Kawarai Lefor A , Yamamoto H
Scand J Gastroenterol.2018 Jul 28 ; ():1-8.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (197view , 0users)

Full Text Sources

Medical

The novel potassium-competitive acid blocker, vonoprazan, provides rapid and effective acid suppression. The aim of this study is to evaluate the long-term outcomes of patients with symptomatic gastroesophageal reflux disease (GERD) treated with vonoprazan.
PMID: 30056768 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード